Clinical Trial Update: Granulocyte-macrophage Colony-stimulating Factor, Interferon and Interleukin-2 as Adjuvant Treatment for Renal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating granulocyte-macrophage colony-stimulating factor, interferon, and interleukin-2 as adjuvant therapy for renal cell carcinoma has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) (sargramostim)
• Interferon Alfa (interferon alfa)
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Kidney Cancer Research Bureau | Conditions: Renal Cell Carcinoma | Phase 2 | Status: COMPLETED